Navigation Links
Boston Heart Diagnostics Awarded $450,000 in Tax Incentives from the Massachusetts Life Sciences Center
Date:3/19/2013

FRAMINGHAM, Mass., March 19, 2013 /PRNewswire/ -- Boston Heart Diagnostics, a pioneer in personalized diagnostics and care plans for patients with or at risk for heart disease, has received $450,000 in tax incentives through the Life Sciences Tax Incentive Program, pledging to create 35 new Massachusetts jobs in 2013.  Boston Heart was one of just 25 companies to receive the tax incentive through the program, which is jointly administered by the Massachusetts Life Sciences Center and the Massachusetts Department of Revenue. Last year, the company received a $220,000 tax incentive through the program, pledging to create 31 Massachusetts full-time-equivalent (FTE) jobs in 2012; in fact the company added 55.

(Logo: http://photos.prnewswire.com/prnh/20110524/NE03671LOGO )

"Boston Heart is the embodiment of what the Life Sciences Tax Incentive Program was designed to achieve, and we are very honored to have received this award, which will help us to continue to realize our ambitious growth goals," commented Boston Heart President and CEO Susan Hertzberg . "This past fall, we were honored to be named one of the top places to work in Massachusetts by the Boston Globe, and a 'Rising Star' winner for the Team Massachusetts Economic Impact Awards, which celebrates companies that have made outstanding contributions to the Massachusetts economy. We are extremely proud of these accomplishments, however, we are prouder still of the important difference we make every day in helping to improve the lives of patients – through our unique panels of diagnostic tests and patient wellness services. We are combining the very latest in diagnostics with a consumer-oriented mindset to create tools, including a patient portal and other mobile touch-points, that drive patient engagement in his or her own heart health and motivate the patient to comply with lifestyle changes that can reduce cardiovascular risk dramatically."

About Boston Heart Diagnostics (BostonHeartDiagnostics.com)
Boston Heart Diagnostics focuses solely on cardiovascular disease – the number one cause of death in the United States. We offer clients an unparalleled combination of proprietary tests, actionable information, and dedicated service and support – partnering with healthcare providers so they can provide the best CVD patient care possible. There's much more to cardiovascular disease than "good" (HDL) and "bad" (LDL) cholesterol. Studies show that traditional statin drug therapy to lower LDL-C reduces the relative risk of heart attack by only 25%. Boston Heart, established in 2007, targets the 75% relative risk for a cardiovascular event that remains AFTER lowering LDL cholesterol. Our proprietary algorithm analyzes test results in light of relevant patient history and the latest peer-reviewed scientific data to produce personalized reports and plans that include specific therapeutic and lifestyle strategies tailored for each individual patient. When it comes to CVD management, Boston Heart Diagnostics is leading the charge to turn the promise of personalized medicine into a reality.

Media contact: Caroline Grossman -- 781.771.5579 -- caroline.grossman@gmail.com


'/>"/>
SOURCE Boston Heart Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
2. Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
3. Sanofi Signs Agreement for Type 1 Diabetes Research with Boston Academic Teaching Hospital
4. Alacrita Establishes U.S. Headquarters in Boston Area
5. BioBDx to Present at the 2012 BioPharm America and AdvaMed MedTech Conferences in Boston
6. Boston Childrens Hospital announces international genomics competition winner
7. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
8. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
9. Boston College researchers unique nanostructure produces novel plasmonic halos
10. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
11. Local Leaders Convene in Boston to Share Industry Best Practices in Second “Business of Big Data” Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 25, 2017 , ... Throughout this webinar, participants will learn ... development and economic goals were achieved in both industry and academic settings. Attendees ... along with techniques for scaling production of mesenchymal stem cells (MSCs) and new ...
(Date:5/24/2017)... WEST BOUNTIFUL, Utah (PRWEB) , ... May 24, ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient ... is a key component of a $24 million plant upgrade to sustainably meet ...
(Date:5/24/2017)... -- As Ebola resurfaces in the Democratic Republic ... cases now reported, a new analysis of the Ebola gene ... between the 2014 and 2017 outbreaks of the disease.  ... which preceded the 2014 outbreak. An analysis of the latest ... in 2014-15, which again precedes the current outbreak in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... its 20th anniversary, marking the occasion with a strong presence at Bio-IT World ... Reception and further extends an invitation to all attendees to view posters ...
Breaking Biology Technology:
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/13/2017)... , April 13, 2017 UBM,s Advanced Design ... will feature emerging and evolving technology through its ... Summits will run alongside the expo portion of the ... panels and demonstrations focused on trending topics within 3D ... design and manufacturing event will take place June 13-15, 2017 ...
(Date:4/11/2017)... April 11, 2017 Crossmatch®, a globally-recognized ... solutions, today announced that it has been awarded ... Projects Activity (IARPA) to develop next-generation Presentation Attack ... "Innovation has been a driving force within ... will allow us to innovate and develop new ...
Breaking Biology News(10 mins):